Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis …

JM Kocarnik, K Compton, FE Dean, W Fu… - JAMA …, 2022 - jamanetwork.com
Importance The Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD
2019) provided systematic estimates of incidence, morbidity, and mortality to inform local …

Evaluation of seropositivity following BNT162b2 messenger RNA vaccination for SARS-CoV-2 in patients undergoing treatment for cancer

A Massarweh, N Eliakim-Raz, A Stemmer… - JAMA …, 2021 - jamanetwork.com
Importance Patients with cancer undergoing treatment are at high risk of COVID-19 following
SARS-CoV-2 infection; however, their ability to produce an adequate antibody response to …

Analyses of risk, racial disparity, and outcomes among US patients with cancer and COVID-19 infection

QQ Wang, NA Berger, R Xu - JAMA oncology, 2021 - jamanetwork.com
Importance Patients with specific cancers may be at higher risk than those without cancer for
coronavirus disease 2019 (COVID-19) and its severe outcomes. At present, limited data are …

Evaluation of COVID-19 mortality and adverse outcomes in US patients with or without cancer

M Chavez-MacGregor, X Lei, H Zhao, P Scheet… - JAMA …, 2022 - jamanetwork.com
Importance As the COVID-19 pandemic continues, understanding the clinical outcomes of
patients with cancer and COVID-19 has become critically important. Objective To compare …

Outcomes of COVID-19 in patients with CLL: a multicenter international experience

AR Mato, LE Roeker, N Lamanna… - Blood, The Journal …, 2020 - ashpublications.org
Given advanced age, comorbidities, and immune dysfunction, chronic lymphocytic leukemia
(CLL) patients may be at particularly high risk of infection and poor outcomes related to …

Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19

MA Thompson, JP Henderson, PK Shah… - JAMA …, 2021 - jamanetwork.com
Importance COVID-19 is a life-threatening illness for many patients. Prior studies have
established hematologic cancers as a risk factor associated with particularly poor outcomes …

Risk factors for hospitalization, mechanical ventilation, or death among 10 131 US veterans with SARS-CoV-2 infection

GN Ioannou, E Locke, P Green, K Berry… - JAMA network …, 2020 - jamanetwork.com
Importance Identifying independent risk factors for adverse outcomes in patients infected
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can support …

Risk factors associated with all-cause 30-day mortality in nursing home residents with COVID-19

OA Panagiotou, CM Kosar, EM White… - JAMA Internal …, 2021 - jamanetwork.com
Importance The coronavirus disease 2019 (COVID-19) pandemic has severely affected
nursing homes. Vulnerable nursing home residents are at high risk for adverse outcomes …

Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set

A Chari, MK Samur, J Martinez-Lopez… - Blood, The Journal …, 2020 - ashpublications.org
The primary cause of morbidity and mortality in patients with multiple myeloma (MM) is an
infection. Therefore, there is great concern about susceptibility to the outcome of COVID-19 …

Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub

WA Wood, DS Neuberg, JC Thompson… - Blood …, 2020 - ashpublications.org
Abstract Coronavirus disease 2019 (COVID-19) is an illness resulting from severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) that emerged in late 2019. Patients with …